Inventor · disambiguated record
Malcolm Huestis
Also filed as: HUESTIS MALCOLM
8 granted patents·5 pending applications·11 citations·filing 2011–2024
80Inventor score
Top patents by PatentIndex Score
13 records- 0190US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0281US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0380US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 0478USRE47848EBiheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 11, 2020·1 cites·56 claims
- 0573US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 0672US9399636B2Substituted dipyridylamines and uses thereofGENENTECH INC·Filed 2014·Granted Jul 26, 2016·2 cites·17 claims
- 0770US2025230147A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0864US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 0960US2023079990A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1057US12187709B2Lactams as CBL-B inhibitors selective over C-CBLGENENTECH INC·Filed 2022·Granted Jan 7, 2025·0 cites·20 claims
- 1152US2024300927A1Amides as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1241US10131675B2Tricyclic DLK inhibitors and uses thereofGENENTECH INC·Filed 2017·Granted Nov 20, 2018·0 cites·34 claims
- 1335US2012157448A1Compounds for treating neurodegenerative diseasesCOOK ADAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Malcolm Huestis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →